Diadema Partners »

Liquidia Technologies shares owned by Diadema Partners

Quarter-by-quarter ownership of Liquidia Technologies (LQDA) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Liquidia Technologies

Tip: Access up to 7 years of quarterly data

All positions including Liquidia Technologies held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liquidia Technologies by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $755k 22k 34.49

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Liquidia Technologies

Farallon Capital Management
Caligan Partners
BlackRock
Vanguard Group
Findell Capital Management
Vanguard Capital Management
Opaleye Management
Bank of America Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
State Street Corporation
Caption Management
MPM Oncology Impact Management
Caprock

View all funds holding Liquidia Technologies